Structure-guided optimization of SLC1A1/EAAT3-selective inhibitors targeting renal cancer metabolism. - Koochaki P; Qiu B; Coker JA; Earsley A; Wang NS; Romigh T; Goins CM; Salem C; Mi D; Days E; Bauer JA; Stauffer SR; et al. (The EMBO journal, 2026)